IOVA
NASDAQ · Biotechnology
Iovance Biotherapeutics Inc
$4.38
-0.06 (-1.35%)
Open$4.53
Previous Close$4.44
Day High$4.77
Day Low$4.35
52W High$5.63
52W Low$1.66
Volume—
Avg Volume13.02M
Market Cap1.75B
P/E Ratio—
EPS$-0.95
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+1,150.5% upside
Current
$4.38
$4.38
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 330.10M | 337.04M | 333.93M |
| Net Income | -489,770,919 | 23.64M | 18.09M |
| Profit Margin | -148.4% | 7.0% | 5.4% |
| EBITDA | -460,270,961 | 42.24M | 40.52M |
| Free Cash Flow | — | 21.56M | 19.96M |
| Rev Growth | — | +17.4% | +6.9% |
| Debt/Equity | 0.00 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |